New paper published in bioRxiv!

Why is the Omicron main protease of SARS-CoV-2 less stable than its wild-type counterpart? A crystallographic,…

New paper published in Nature Communications!

Multiple redox switches of the SARS-CoV-2 main protease in vitro provide opportunities for drug design

Prof. Rolf Hilgenfeld was listed on the Web of Science Highly Cited Researchers 2022 list

New paper published in Nature Scientific Reports: Congratulations Yuan for being co-author!

Ebselen derivatives inhibit SARS-CoV-2 replication by…

Prof. Rolf Hilgenfeld was awarded the Thomas-Fredenhagen-Prize for technology transfer